Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-160132

Options or other derivatives

  • Director acquired 288,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kerr Giles Francis Bertram Director 2016-11-29 Grant or award · Option to purchase Ordinary Shares +288,000 288,000 D
Loading xslF345X03/a4.xml…